Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. ERAS
2. SPRO
3. JPM
4. AAPL
5. NFLX
6. HCLT:IN
7. TREX
8. RPAY
9. SPY
10. WFC

Go back to Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
(NASDAQ: CNTX) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High $ 
Open $0.62    52 Week Low $ 
Day High $0.62    P/E N/A 
Day Low $0.62    EPS $ 
Volume 1,526       

(NASDAQ: CNTX) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High $ 
Open $0.62    52 Week Low $ 
Day High $0.62    P/E N/A 
Day Low $0.62    EPS $ 
Volume 1,526